Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

75%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

3(75.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 13 (75.0%)

Phase 31 (25.0%)

Trials by Status

completed375%

recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

recruitingphase_3

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

NCT07174336

completedphase_1

A Study of [14C]-LY4064809 in Healthy Participants

NCT07519525

completedphase_1

A Study of LY4064809 in Healthy Adult Chinese Participants

NCT07247357

completedphase_1

A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants

NCT06991179

Clinical Trials (4)

Showing 4 of 4 trials

NCT07174336Phase 3

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Recruiting

NCT07519525Phase 1

A Study of [14C]-LY4064809 in Healthy Participants

Completed

NCT07247357Phase 1

A Study of LY4064809 in Healthy Adult Chinese Participants

Completed

NCT06991179Phase 1

A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4